Douglass Winthrop Advisors LLC cut its holdings in shares of Aetna Inc (NYSE:AET) by 15.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,000 shares of the company’s stock after selling 550 shares during the quarter. Douglass Winthrop Advisors LLC’s holdings in Aetna were worth $609,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of the stock. FMR LLC increased its holdings in shares of Aetna by 3.5% during the 2nd quarter. FMR LLC now owns 7,734,487 shares of the company’s stock worth $1,419,279,000 after acquiring an additional 261,463 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Aetna by 0.8% during the 2nd quarter. Northern Trust Corp now owns 3,803,810 shares of the company’s stock worth $697,999,000 after acquiring an additional 28,520 shares during the last quarter. PointState Capital LP increased its holdings in shares of Aetna by 111.2% during the 2nd quarter. PointState Capital LP now owns 2,193,062 shares of the company’s stock worth $402,427,000 after acquiring an additional 1,154,818 shares during the last quarter. Summit Trail Advisors LLC increased its holdings in shares of Aetna by 55,803.4% during the 1st quarter. Summit Trail Advisors LLC now owns 1,616,727 shares of the company’s stock worth $1,617,000 after acquiring an additional 1,613,835 shares during the last quarter. Finally, Abrams Capital Management L.P. increased its holdings in shares of Aetna by 14.1% during the 2nd quarter. Abrams Capital Management L.P. now owns 1,575,000 shares of the company’s stock worth $289,013,000 after acquiring an additional 195,000 shares during the last quarter. 83.49% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE AET opened at $201.01 on Friday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. Aetna Inc has a one year low of $149.69 and a one year high of $206.66. The firm has a market capitalization of $66.41 billion, a price-to-earnings ratio of 20.39, a PEG ratio of 1.74 and a beta of 0.69.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date of this dividend is Tuesday, October 23rd. Aetna’s dividend payout ratio is 20.28%.
A number of research firms recently weighed in on AET. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a report on Tuesday, June 26th. Zacks Investment Research lowered Aetna from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $202.00 price objective on shares of Aetna in a report on Thursday, August 2nd. Eight equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Aetna currently has a consensus rating of “Hold” and a consensus target price of $203.77.
Aetna Company Profile
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.